Pantotenat Kinaz ile İlgili Nörodejenerasyon PKAN ‘a Bağlı Distonide Derin Beyin Stimülasyonu

Uğur Işık; Yasemin Akgün; Selçuk Peker; Memet Özek

Deep Brain Stimulation In Dystonia Secondary To Pantothenate Kinase-Associated Neurodegeneration Pkan

Yıl 2012, Sayı: 1, 72 - 75, 01.03.2012

Uğur Işık Yasemin Akgün Selçuk Peker Memet Özek

Öz

Pantothenate kinase-associated neurodegeneration PKAN is a rare autosomal recessive disorder with childhood onset and rapid progression. There is no effective medical therapy for this disorder. Stereotactic surgery consisting of thalomotomy and pallidotomy has been performed for medically refractory severe dystonia. Recently, deep brain stimulation DBS of globus pallidus GP has emerged as an alternative treatment in intractable dystonia. Three patients with PKAN-related dystonia, two of which demonstrated good response to bilateral globus pallidus internus GPi DBS are reported here

Anahtar Kelimeler

Deep brain stimulation, dystonia, PKAN

Kaynakça

Gregory A, Hayflick SJ. Neurodegeneration with brain iron accumulation. Folia Neuropathol 2005;43:286-96
Zhou B, Westaway SK, Levinson B, Johnson MA, Gitschier J, Hayflick SJ. A novel pantothenate kinase gene (PANK2) is defective in Hallervorden- Spatz syndrome. Nat Genet 2001; 28:345-9
Iacono RP, Kuniyoshi SM, Lonser RR, Maeda G, Inae AM, Ashwal S. Simultaneous bilateral pallidoansotomy for idiopathic dystonia musculorum deformans. Pediatr Neurol 1996; 14:145-8.
Justesen CR, Penn RD, Kroin JS, Egel RT. Sterotactic pallidotomy in a child with Hallervorden-Spatz disease. Case report. J Neurosurg 1999;90:551-4
Lozano AM, Kumar R, Gross RE, Giladi N, Hutchison WD, Dostrovsky JO ve ark. Globus pallidus internus pallidotomy for generalized dystonia. Mov Disord 1997; 12:865-70
Ondo WG, Desaloms JM, Jankovic J, Grossman RG. Pallidotomy for generalized dystonia. Mov Disord 1998; 13:693-8
Tsukamoto H, Inui K, Taniike M, Nishimoto J, Midorikawa M, Yoshimine T ve ark . A case of Hallervorden-Spatz disease: progressive and intractable dystonia controlled by bilateral thalamotomy. Brain Dev1992;14:269-72
Krause M, Fogel W, Kloss M, Rasche D, Volkmann J, Tronnier V. Pallidal stimulation for dystonia. Neurosurgery 2004; 55:1361-8
Umemura A, Jaggi JL, Dolinskas CA, Stern MB, Baltuch GH. Pallidal deep brain stimulation for longstanding severe genralized dystonia in Hallervorden-Spatz syndrome. J Neurosurg 2004;100:706-9
Vercueil L, Pollak P, Fraix V, Caputo E, Moro E, Benazzouz A ve ark. Deep brain stimulation in the treatment of severe dystonia. J Neurol 2001;248:695-700.
Hayflick SJ, Penzien JM, Michl W, Sharif UM, Rosman NP, Wheeler PG. Cranial MRI changes may precede symptoms in Hallervorden-Spatz syndrome. Pediatr Neurol 2001;25:166-9.
Savoiardo M, Halliday WC, Nardocci N, Strada L, D’Incerti L, Angelini L ve ark. Hallervorden-Spatz disease: MR and pathologic findings. AJNR Am J Neuroradiol 1993;14:155-62
Gil-Robles S, Cif L, Biolsi B, Tancu C, El Fertit H, Coubes P. Neurosurgical treatment in childhood dystonias and dyskinesias. Rev Neurol 2006;43 Suppl1:S169-72.
Castelnau P, Cif L, Valente EM, Vayssiere N, Hemm S, Gannau A ve ark. Pallidal stimulation improves pantothenate kinase-associated neurodegeneration. Ann Neurol 2005;57:738-41.
Krause M, Fogel W, Tronnier V, Pohle S, Hortnagel K, Thyen U ve ark. Long-term benefit to pallidal deep brain stimulation in a case of dystonia secondary to pantothenate kinase-associated neurodegeneration. Mov Disord 2006;21:2255-7
Mikati MA, Yehya A, Darwish H, Karam P, Comair Y. Deep brain stimulation as a mode of treatment of early onset pantothenate kinase-associated neurodegeneration. Eur J Paediatr Neurol 2009; 13:61-4.
Gregory A, Hayflick SJ. Pantothenate-kinase associated neurodegeneration. In: GeneReviews [Internet] Pagon RA, Bird TC, Dolan CR and Stephens K Eds. Seattle (WA): University of Washington, Seattle, 1993-2002.
Lim BC, Ki CS, Cho A, Hwang H, Kim KJ, Hwang YS ve ark. Pantothenate kinase-associated neurodegeneration in Korea:recurrent R440P mutation in PANK2 and outcome of deep brain stimulation. Europ J Neurol 2011;doi:10.1111/j.1468-1331.2011.03589.x.